vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and TRUPANION, INC. (TRUP). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $376.9M, roughly 1.3× TRUPANION, INC.). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 11.7%). TRUPANION, INC. produced more free cash flow last quarter ($25.3M vs $-68.7M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 11.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Trupanion, Inc. is a pet insurance provider headquartered in Seattle, Washington. Established in 1998, Trupanion operates across the United States, Canada, Australia, and Puerto Rico. The company offers coverage for pets and is self-underwritten by the American Pet Insurance Company (APIC).

CLOV vs TRUP — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$376.9M
TRUP
Growing faster (revenue YoY)
CLOV
CLOV
+33.0% gap
CLOV
44.7%
11.7%
TRUP
More free cash flow
TRUP
TRUP
$94.1M more FCF
TRUP
$25.3M
$-68.7M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
11.0%
TRUP

Income Statement — Q4 2025 vs Q4 2025

Metric
CLOV
CLOV
TRUP
TRUP
Revenue
$487.7M
$376.9M
Net Profit
$-49.3M
Gross Margin
17.3%
Operating Margin
-10.1%
1.9%
Net Margin
-10.1%
Revenue YoY
44.7%
11.7%
Net Profit YoY
-123.2%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TRUP
TRUP
Q4 25
$487.7M
$376.9M
Q3 25
$496.6M
$366.9M
Q2 25
$477.6M
$353.6M
Q1 25
$462.3M
$342.0M
Q4 24
$337.0M
$337.3M
Q3 24
$331.0M
$327.5M
Q2 24
$356.3M
$314.8M
Q1 24
$346.9M
$306.1M
Net Profit
CLOV
CLOV
TRUP
TRUP
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
TRUP
TRUP
Q4 25
17.3%
Q3 25
16.4%
Q2 25
15.5%
Q1 25
14.9%
Q4 24
15.7%
Q3 24
24.5%
15.1%
Q2 24
30.3%
12.8%
Q1 24
23.6%
11.8%
Operating Margin
CLOV
CLOV
TRUP
TRUP
Q4 25
-10.1%
1.9%
Q3 25
-4.9%
1.6%
Q2 25
-2.2%
0.7%
Q1 25
-0.3%
-0.4%
Q4 24
-6.4%
0.1%
Q3 24
-2.7%
0.5%
Q2 24
2.0%
-1.7%
Q1 24
-6.5%
-2.0%
Net Margin
CLOV
CLOV
TRUP
TRUP
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
TRUP
TRUP
Q4 25
$0.13
Q3 25
$0.13
Q2 25
$0.22
Q1 25
$-0.03
Q4 24
$0.04
Q3 24
$0.03
Q2 24
$-0.14
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TRUP
TRUP
Cash + ST InvestmentsLiquidity on hand
$78.3M
$370.7M
Total DebtLower is stronger
$101.8M
Stockholders' EquityBook value
$308.7M
$383.9M
Total Assets
$541.0M
$915.0M
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TRUP
TRUP
Q4 25
$78.3M
$370.7M
Q3 25
$348.5M
Q2 25
$319.6M
Q1 25
$321.8M
Q4 24
$194.5M
$307.4M
Q3 24
$288.0M
$293.1M
Q2 24
$254.8M
$277.2M
Q1 24
$208.3M
$275.2M
Total Debt
CLOV
CLOV
TRUP
TRUP
Q4 25
$101.8M
Q3 25
Q2 25
Q1 25
Q4 24
$127.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
TRUP
TRUP
Q4 25
$308.7M
$383.9M
Q3 25
$340.9M
$368.6M
Q2 25
$344.2M
$355.5M
Q1 25
$336.1M
$333.7M
Q4 24
$341.1M
$323.3M
Q3 24
$342.2M
$320.2M
Q2 24
$324.9M
$305.8M
Q1 24
$292.5M
$303.4M
Total Assets
CLOV
CLOV
TRUP
TRUP
Q4 25
$541.0M
$915.0M
Q3 25
$559.7M
$880.2M
Q2 25
$575.0M
$847.8M
Q1 25
$583.7M
$837.2M
Q4 24
$580.7M
$806.9M
Q3 24
$653.0M
$816.1M
Q2 24
$674.2M
$795.9M
Q1 24
$671.8M
$789.5M
Debt / Equity
CLOV
CLOV
TRUP
TRUP
Q4 25
0.27×
Q3 25
Q2 25
Q1 25
Q4 24
0.39×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TRUP
TRUP
Operating Cash FlowLast quarter
$-68.2M
$29.3M
Free Cash FlowOCF − Capex
$-68.7M
$25.3M
FCF MarginFCF / Revenue
-14.1%
6.7%
Capex IntensityCapex / Revenue
0.1%
1.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.0M
$75.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TRUP
TRUP
Q4 25
$-68.2M
$29.3M
Q3 25
$12.1M
$29.2M
Q2 25
$5.4M
$15.0M
Q1 25
$-16.3M
$16.0M
Q4 24
$-85.8M
$23.7M
Q3 24
$50.0M
$15.3M
Q2 24
$44.8M
$6.9M
Q1 24
$25.9M
$2.4M
Free Cash Flow
CLOV
CLOV
TRUP
TRUP
Q4 25
$-68.7M
$25.3M
Q3 25
$11.4M
$23.9M
Q2 25
$4.8M
$12.0M
Q1 25
$-16.5M
$14.0M
Q4 24
$-86.1M
$21.8M
Q3 24
$49.6M
$13.4M
Q2 24
$44.4M
$4.0M
Q1 24
$25.5M
$-631.0K
FCF Margin
CLOV
CLOV
TRUP
TRUP
Q4 25
-14.1%
6.7%
Q3 25
2.3%
6.5%
Q2 25
1.0%
3.4%
Q1 25
-3.6%
4.1%
Q4 24
-25.6%
6.5%
Q3 24
15.0%
4.1%
Q2 24
12.5%
1.3%
Q1 24
7.3%
-0.2%
Capex Intensity
CLOV
CLOV
TRUP
TRUP
Q4 25
0.1%
1.0%
Q3 25
0.1%
1.4%
Q2 25
0.1%
0.8%
Q1 25
0.0%
0.6%
Q4 24
0.1%
0.6%
Q3 24
0.1%
0.6%
Q2 24
0.1%
0.9%
Q1 24
0.1%
1.0%
Cash Conversion
CLOV
CLOV
TRUP
TRUP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons